Advertisement
Screener

Definium Therapeutics, Inc. (DFTX) Amortization of Intangible Assets

2.8 / 5 stars · 68/120 Roast Me

Definium Therapeutics, Inc. Amortization of Intangible Assets

Definium Therapeutics, Inc. (DFTX) reported Amortization of Intangible Assets of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2026-02-26

  • Definium Therapeutics, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $0.00.
  • Definium Therapeutics, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $0.00.
  • Definium Therapeutics, Inc. amortization of intangible assets for the quarter ending 2025-06-30 was $0.00.
  • Definium Therapeutics, Inc. amortization of intangible assets for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
  • Definium Therapeutics, Inc. amortization of intangible assets for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • Definium Therapeutics, Inc. amortization of intangible assets for fiscal 2024 was $527.00K, a 83.33% decline from fiscal 2023.
  • Definium Therapeutics, Inc. amortization of intangible assets for fiscal 2023 was $3.16M, a 0.57% decline from fiscal 2022.
  • Definium Therapeutics, Inc. amortization of intangible assets for fiscal 2022 was $3.18M, a 21.56% increase from fiscal 2021.
Period endAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 6 month as first filedAmortization of Intangible Assets 7 monthAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 12 month
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
10-K · filed 2026-02-26
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$0.00
derived: sum of 2 quarters · filed 2025-11-06
$0.00
10-Q · filed 2025-11-06
$0.00
derived: sum of 4 quarters · filed 2026-02-26
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
$0.00
10-Q · filed 2025-07-31
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
derived: sum of 4 quarters · filed 2026-02-26
2025-03-31$0.00
10-Q · filed 2025-05-08
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
derived: sum of 4 quarters · filed 2026-02-26
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$527.00K
10-K · filed 2026-02-26
2024-09-30$0.00
10-Q · filed 2024-11-07
$0.00
derived: sum of 2 quarters · filed 2024-11-07
$527.00K
10-Q · filed 2025-11-06
$1.32M
derived: sum of 4 quarters · filed 2025-05-08
2024-06-30$0.00
10-Q · filed 2024-08-13
$527.00K
10-Q · filed 2025-07-31
$1.32M
derived: sum of 3 quarters · filed 2025-05-08
$2.12M
derived: sum of 4 quarters · filed 2025-05-08
2024-03-31$527.00K
10-Q · filed 2025-05-08
$1.32M
derived: sum of 2 quarters · filed 2025-05-08
$2.12M
derived: sum of 3 quarters · filed 2025-05-08
$2.92M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$790.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
$1.59M
derived: sum of 2 quarters · filed 2025-03-06
$2.39M
derived: sum of 3 quarters · filed 2025-03-06
$3.16M
10-K · filed 2025-03-06
2023-09-30$800.00K
10-Q · filed 2024-11-07
$1.60M
derived: sum of 2 quarters · filed 2024-11-07
$2.37M
10-Q · filed 2024-11-07
$3.18M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$800.00K
10-Q · filed 2024-08-13
$1.58M
10-Q · filed 2024-08-13
$2.38M
derived: sum of 3 quarters · filed 2024-08-13
$3.18M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$791.00K
10-Q · filed 2024-05-08
$1.58M
derived: sum of 2 quarters · filed 2024-05-08
$2.38M
derived: sum of 3 quarters · filed 2024-05-08
$3.18M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31$790.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$1.59M
derived: sum of 2 quarters · filed 2024-02-28
$2.39M
derived: sum of 3 quarters · filed 2024-02-28
$3.18M
10-K · filed 2024-02-28
2022-09-30$800.00K
10-Q · filed 2023-11-02
$1.60M
derived: sum of 2 quarters · filed 2023-11-02
$2.39M
10-Q · filed 2023-11-02
$3.17M
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30$800.00K
10-Q · filed 2023-08-03
$1.60M
10-Q · filed 2023-08-03
$2.37M
derived: sum of 3 quarters · filed 2023-08-03
$3.17M
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31$780.00K
10-Q · filed 2023-05-04
$1.57M
derived: sum of 2 quarters · filed 2023-05-04
$2.37M
derived: sum of 3 quarters · filed 2023-05-04
$3.17M
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31$788.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
$1.59M
derived: sum of 2 quarters · filed 2023-03-09
$2.39M
derived: sum of 3 quarters · filed 2023-03-09
$2.62M
10-K · filed 2023-03-09
2021-09-30$800.00K
10-Q · filed 2022-11-10
$1.60M
derived: sum of 2 quarters · filed 2022-11-10
$1.83M
10-Q · filed 2022-11-10
2021-06-30$800.00K
10-Q · filed 2022-08-11
$1.60M
10-Q · filed 2023-08-03
$1.04M
10-Q · filed 2022-08-11
2021-03-31$260.00K
10-Q · filed 2022-05-16
2020-12-31$0.00
10-K · filed 2022-03-28
2019-12-31$0.00
10-K · filed 2022-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cronos Group Inc. (CRON)$1.223B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B